Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Cardiology Clinics|April 15, 2020
Right Heart Failure in Pulmonary HypertensionSteven J Cassady, Gautam V RamaniMedicina (Kaunas, Lithuania)|August 7, 2019
Pulmonary Hypertension in COPD: A Case Study and Review of the LiteratureSteven J Cassady, Robert M ReedChest|June 1, 2020
Phenotypes of Bronchopulmonary Dysplasia in AdultsSteven J Cassady, Anayansi Lasso-Pirot, Janaki DeepakDrug, Healthcare and Patient Safety|June 10, 2024
Therapeutic Potential of Treprostinil Inhalation Powder for Patients with Pulmonary Arterial Hypertension: Evidence to DateSteven J Cassady, Jose Alejandro N Almario, Gautam V RamaniNeurobiology of Disease|September 21, 2010
Integrating multiple aspects of mitochondrial dynamics in neurons: age-related differences and dynamic changes in a chronic rotenone modelBeth Arnold, Steven J Cassady, Victor S VanLaar, et al.Pulmonary Circulation|November 12, 2025
Real-World Comparison of Patients With PH-ILD Initiating Inhaled Treprostinil Versus Patients Who Remain UntreatedSteven J Cassady, Gautam V Ramani, Benjamin Wu, et al.Physiological Reports|July 9, 2025
Left ventricular concentric remodeling is highly common among veterans deployed to Southwest Asia and is associated with impaired exercise performanceSteven J Cassady, Thomas J Abitante, Gregory G Pappas, et al.Human Molecular Genetics|December 15, 2010
Bioenergetics of neurons inhibit the translocation response of Parkin following rapid mitochondrial depolarizationVictor S Van Laar, Beth Arnold, Steven J Cassady, et al.Pulmonary Circulation|May 28, 2024
Diagnosis and management of chronic thromboembolic pulmonary hypertension (CTEPH) in sickle cell disease: A reviewKadija Hersi, Gautam V Ramani, Jennie Y Law, et al.Advances in Therapy|November 10, 2025
Transitioning Between Treprostinil Formulations: Evidence and StrategiesMegan Clarke, Ali Ataya, Alison M Turkin, et al.Pageof 2